Sakurasaku Plus
7097
Timee
215A
Wintest
6721
Heartseed
219A
Raksul
4384
JP Stock MarketDetailed Quotes
4883 Modalis Therapeutics
- 111
- 00.00%
20min DelayNot Open Dec 13 15:30 JST
7.70BMarket Cap-1.44P/E (Static)
115High110Low5.90MVolume113Open111Pre Close665.54MTurnover20352wk High9.50%Turnover Ratio69.40MShares6252wk Low-64.98EPS TTM6.90BFloat Cap4070Historical HighLossP/E (Static)62.16MShs Float62Historical Low-77.24EPS LYR4.51%Amplitude--Dividend TTM5.65P/B100Lot Size--Div YieldTTM
Modalis Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | |
|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||
| Cash from operating activities | -19.08%-2.25B | -53.24%-1.89B | -227.98%-1.23B | -265.19%-375.76M | 207.32%227.47M | -211.95M |
| Net profit before non-cash adjustment | 11.69%-2.39B | -263.16%-2.71B | -69.59%-745.42M | -400.34%-439.55M | 168.58%146.35M | ---213.39M |
| Total adjustment of non-cash items | -87.05%101.8M | 250.66%786.03M | -633.42%-521.71M | 209.72%97.81M | 407.49%31.58M | ---10.27M |
| -Depreciation and amortization | -99.41%731K | 58.82%123.68M | 35.22%77.87M | 760.42%57.59M | 1,501.20%6.69M | --418K |
| -Reversal of impairment losses recognized in profit and loss | -96.11%38.82M | --996.8M | --0 | ---- | ---- | ---- |
| -Disposal profit | --0 | -73.68%552K | --2.1M | --0 | ---- | ---- |
| -Net exchange gains and losses | 46.95%-27.86M | -347.79%-52.52M | -445.68%-11.73M | --3.39M | ---- | ---- |
| -Remuneration paid in stock | -10.22%9.64M | 86.29%10.74M | --5.76M | --0 | ---- | ---- |
| -Other non-cash items | 127.45%80.47M | 50.78%-293.21M | -1,717.72%-595.71M | 47.97%36.82M | 332.84%24.89M | ---10.69M |
| Changes in working capital | 22.86%39.94M | -6.39%32.51M | 202.08%34.72M | -168.66%-34.02M | 323.11%49.54M | --11.71M |
| -Change in receivables | -142.25%-9.56M | 232.08%22.62M | -603.08%-17.13M | -101.32%-2.44M | -126.25%-1.21M | --4.61M |
| -Change in payables | -202.98%-22.36M | -51.99%21.71M | 227.30%45.22M | -175.75%-35.52M | 6,770.13%46.89M | ---703K |
| -Change in accrued expense | 707.54%71.85M | -278.34%-11.83M | 68.21%6.63M | 2.20%3.94M | -50.56%3.86M | --7.8M |
| Dividends paid (cash flow from operating activities) | ||||||
| Dividends received (cash flow from operating activities) | ||||||
| Interest paid (cash flow from operating activities) | 27.97%-4.41M | -6.13M | 0 | |||
| Interest received (cash flow from operating activities) | -56.14%25K | 0.00%57K | 9.62%57K | 160.00%52K | 100.00%20K | 10K |
| Tax refund paid | 0.00%-1.21M | 0.00%-1.21M | -27.37%-1.21M | 75.12%-950K | -165.02%-3.82M | -1.44M |
| Other operating cash inflow (outflow) | 0 | 0 | 615,200.00%486.09M | -83.47%79K | -38.24%478K | 774K |
| Operating cash flow | -18.92%-2.25B | -153.63%-1.9B | -98.49%-747.47M | -268.00%-376.58M | 205.43%224.15M | ---212.61M |
| Investing cash flow | ||||||
| Net PPE purchase and sale | 79.88%-39.7M | -84.19%-197.29M | -607.10%-107.11M | 72.09%-15.15M | -9,805.84%-54.28M | ---548K |
| Net intangibles purchase and sale | ---- | ---- | 140.46%329.67M | ---814.87M | ---- | ---- |
| Net changes in other investments | ---- | 122.68%11.57M | -17,128.38%-51M | 96.05%-296K | -16.08%-7.49M | ---6.45M |
| Investing cash flow | 78.62%-39.7M | -208.25%-185.72M | 120.66%171.56M | -1,244.22%-830.31M | -782.92%-61.77M | ---7M |
| Financing cash flow | ||||||
| Net issuance payments of debt | --488.46M | --0 | ---- | ---- | ---- | ---- |
| Net common stock issuance | 1,108.63%736.12M | -16.15%60.91M | -97.40%72.63M | 12.34%2.8B | --2.49B | ---- |
| Issuance fees | ---- | ---- | ---- | ---20.1M | ---- | ---- |
| Net other fund-raising expenses | -392.66%-8.13M | 277,900.00%2.78M | 99.41%-1K | 20.28%-169K | 15.20%-212K | ---250K |
| Financing cash flow | 1,810.17%1.22B | -12.32%63.68M | -97.39%72.63M | 11.54%2.78B | 996,341.20%2.49B | ---250K |
| Net cash flow | ||||||
| Beginning cash position | -40.58%2.93B | -8.95%4.94B | 40.55%5.42B | 220.06%3.86B | -15.42%1.21B | --1.42B |
| Current changes in cash | 46.59%-1.08B | -300.94%-2.02B | -132.03%-503.27M | -40.78%1.57B | 1,306.70%2.65B | ---219.85M |
| Effect of exchange rate changes | 89.40%27.99M | -17.84%14.78M | 362.01%17.99M | -671.35%-6.87M | -749.64%-890K | --137K |
| Cash adjustments other than cash changes | ---- | ---- | ---- | ---1K | ---- | ---1K |
| End cash Position | -35.79%1.88B | -40.58%2.93B | -8.95%4.94B | 40.55%5.42B | 220.06%3.86B | --1.21B |
| Free cash flow | -9.61%-2.29B | -144.92%-2.09B | 29.17%-854.58M | -810.33%-1.21B | 179.69%169.86M | ---213.16M |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |